Chosen among ten shared proteins between CSF and plasma EV proteomes associated with MS relapses, EAAT2 on plasma EV surface detected by using a novel and highly reproducible flow cytometry-based approach, showed to be a promising biomarker of MS relapses. The gene discussed is SLC1A2; the disease is myeloid sarcoma.